Skip to main content
Public Health Reports logoLink to Public Health Reports
. 2004 Jan-Feb;119(1):25–31. doi: 10.1016/j.phr.2004.03.008

The Massachusetts HIV, hepatitis, addiction services integration (HHASI) experience: responding to the comprehensive needs of individuals with co-occurring risks and conditions.

Heidi L Hoffman 1, Carolyn A Castro-Donlan 1, Victoria M Johnson 1, Daniel R Church 1
PMCID: PMC1502249  PMID: 15147646

Abstract

Categorical funding mechanisms traditionally used to fund public health programs are a challenge to providers serving individuals with complex needs that often span multiple service areas. Integration--a formalized, collaborative process among service systems--responds to the challenge by decreasing fragmentation of care and improving coordination. In 2000, the Massachusetts Department of Public Health (MDPH) received a one-year planning grant from the federal Substance Abuse and Mental Health Services Administration (SAMHSA) to evaluate opportunities for integrating HIV/AIDS programs and substance abuse treatment programs. The project was later expanded to include viral hepatitis programming. Outcomes include the development of a strategic plan, joint procurement initiatives, and an ongoing commitment to sustain inter-bureau integration efforts, even in the face of substantial budget reductions. Integrated approaches can promote greater efficiency, improving communication and coordination among clients, providers, and government funding agencies.

Full Text

The Full Text of this article is available as a PDF (60.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Centers for Disease Control and Prevention (CDC) Prevalence of hepatitis C virus infection among clients of HIV counseling and testing sites--Connecticut, 1999. MMWR Morb Mortal Wkly Rep. 2001 Jul 13;50(27):577–581. [PubMed] [Google Scholar]
  2. Edlin B. R., Irwin K. L., Faruque S., McCoy C. B., Word C., Serrano Y., Inciardi J. A., Bowser B. P., Schilling R. F., Holmberg S. D. Intersecting epidemics--crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team. N Engl J Med. 1994 Nov 24;331(21):1422–1427. doi: 10.1056/NEJM199411243312106. [DOI] [PubMed] [Google Scholar]
  3. Garfein R. S., Vlahov D., Galai N., Doherty M. C., Nelson K. E. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health. 1996 May;86(5):655–661. doi: 10.2105/ajph.86.5.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Grella C. E., Anglin M. D., Wugalter S. E. Cocaine and crack use and HIV risk behaviors among high-risk methadone maintenance clients. Drug Alcohol Depend. 1995 Jan;37(1):15–21. doi: 10.1016/0376-8716(94)01059-t. [DOI] [PubMed] [Google Scholar]
  5. Leigh B. C., Stall R. Substance use and risky sexual behavior for exposure to HIV. Issues in methodology, interpretation, and prevention. Am Psychol. 1993 Oct;48(10):1035–1045. doi: 10.1037//0003-066x.48.10.1035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Murrill Christopher S., Weeks Howard, Castrucci Brian C., Weinstock Hillard S., Bell Beth P., Spruill Catherine, Gwinn Marta. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health. 2002 Mar;92(3):385–387. doi: 10.2105/ajph.92.3.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Sherman Kenneth E., Rouster Susan D., Chung Raymond T., Rajicic Natasa. Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002 Feb 6;34(6):831–837. doi: 10.1086/339042. [DOI] [PubMed] [Google Scholar]

Articles from Public Health Reports are provided here courtesy of SAGE Publications

RESOURCES